These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 34885033)
1. The Clinical Feature and Treatment Outcome of Ocular Melanoma: A 34-Year Experience in a Tertiary Referral Center. Huang YY; Hou TY; Yu WK; Tsai CC; Kao SC; Hsu WM; Liu JC Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885033 [TBL] [Abstract][Full Text] [Related]
2. Presentation, Treatment, and Prognosis of Secondary Melanoma within the Orbit. Rose AM; Cowen S; Jayasena CN; Verity DH; Rose GE Front Oncol; 2017; 7():125. PubMed ID: 28690979 [TBL] [Abstract][Full Text] [Related]
3. Experience with eyelid-sparing orbital exenteration: the 2000 Tullos O. Coston Lecture. Shields JA; Shields CL; Demirci H; Honavar SG; Singh AD Ophthalmic Plast Reconstr Surg; 2001 Sep; 17(5):355-61. PubMed ID: 11642492 [TBL] [Abstract][Full Text] [Related]
7. Clinical Spectrum and Management Outcome of Ocular and Adnexal Rhinosporidiosis. Alam MS; Shrirao N J Curr Ophthalmol; 2022; 34(3):341-346. PubMed ID: 36644476 [TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node biopsy for sebaceous cell carcinoma and melanoma of the ocular adnexa. Ho VH; Ross MI; Prieto VG; Khaleeq A; Kim S; Esmaeli B Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):820-6. PubMed ID: 17709624 [TBL] [Abstract][Full Text] [Related]
10. Secondary orbital melanomas: analysis of 15 cases. Liarikos S; Rapidis AD; Roumeliotis A; Angelopoulos AP J Craniomaxillofac Surg; 2000 Jun; 28(3):148-52. PubMed ID: 10964550 [TBL] [Abstract][Full Text] [Related]
11. Lymphoid hyperplasia and malignant lymphoma occurring in the ocular adnexa (orbit, conjunctiva, and eyelids): a prospective multiparametric analysis of 108 cases during 1977 to 1987. Knowles DM; Jakobiec FA; McNally L; Burke JS Hum Pathol; 1990 Sep; 21(9):959-73. PubMed ID: 2394438 [TBL] [Abstract][Full Text] [Related]
12. Primary Orbital Melanoma: Presentation, Treatment, and Long-term Outcomes for 13 Patients. Rose AM; Luthert PJ; Jayasena CN; Verity DH; Rose GE Front Oncol; 2017; 7():316. PubMed ID: 29326884 [TBL] [Abstract][Full Text] [Related]
14. Ocular melanoma. Char DH Surg Clin North Am; 2003 Apr; 83(2):253-74, vii. PubMed ID: 12744609 [TBL] [Abstract][Full Text] [Related]
15. Extrascleral extension of choroidal melanoma: post-enucleation high-dose-rate interstitial brachytherapy of the orbit. Finger PT; Tena LB; Semenova E; Aridgides P; Choi WH Brachytherapy; 2014; 13(3):275-80. PubMed ID: 24139892 [TBL] [Abstract][Full Text] [Related]
16. Ocular adnexal lymphoproliferative disorders in an ophthalmic referral center in Saudi Arabia. Alkatan HM; Alaraj A; El-Khani A; Al-Sheikh O Saudi J Ophthalmol; 2013 Jul; 27(3):227-30. PubMed ID: 24227991 [TBL] [Abstract][Full Text] [Related]
17. Clinical features predictive of orbital exenteration for conjunctival melanoma. Shields JA; Shields CL; Gündüz K; Cater J Ophthalmic Plast Reconstr Surg; 2000 May; 16(3):173-8. PubMed ID: 10826757 [TBL] [Abstract][Full Text] [Related]
18. Malignant melanoma of the eyelid and palpebral conjunctiva treated with iodine-125 brachytherapy. Stannard CE; Sealy GR; Hering ER; Pereira SB; Knowles R; Hill JC Ophthalmology; 2000 May; 107(5):951-8. PubMed ID: 10811089 [TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic features and survival outcomes of ocular melanoma: a series of 31 cases from a tertiary university hospital. Kestel S; Göçün FPU; Öğüt B; Erdem Ö J Pathol Transl Med; 2022 Jul; 56(4):187-198. PubMed ID: 35501671 [TBL] [Abstract][Full Text] [Related]